EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The FGFRL1–FASN axis regulates neuroendocrine lineage transdifferentiation by modulating fatty acid synthesis in AR pathway-independent prostate cancer

Yupeng Chen, Jiarun Lai, Jian Chen, Ziqing Zhou, Qianfeng Xu, Rui Zhou, Jinchuang Li, Yusen Long, Ailiyaerjiang Wureyimu, Jiaming Su, Xinyue Mei, Yinglin Li und 6 weitere

Cancer Letters · 2026

DOI: 10.1016/j.canlet.2026.218769 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2026. Verfasst von Yupeng Chen und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, School of Medicine, The Second Affiliated Hospital of South China University of Technology (Guangzhou First People's Hospital)…. Hauptthemen laut MEDLINE: Cell Transdifferentiation, Fatty Acid Synthase, Type I, Fatty Acids, Prostatic Neoplasms, Castration-Resistant. Die Arbeit nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fundo para o Desenvolvimento das Ciências e da Tecnologia, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AR pathway-independent prostate cancer (ARIPC), particularly neuroendocrine prostate cancer (NEPC), represents one of the most lethal states of metastatic castration-resistant prostate cancer. However, how fatty acid synthesis (FAS) is organized in ARIPC and whether distinct lipogenic states shape neuroendocrine lineage transdifferentiation remain unclear. By integrating single-cell and bulk transcriptomic analyses of mCRPC cohorts, we identify NEPC as a fatty-acid-synthesis-low state associated with poor survival. Within this context, fatty acid synthase (FASN) emerges as a key indicator and functional contributor to lipogenic activity. FASN depletion suppresses lipogenesis while increasing NEPC-associated programs, migration, and metastatic colonization. We further identify FGFRL1 as the FGF family member most consistently associated with fatty acid synthesis activity in ARIPC. FGFRL1 depletion reduces FASN expression and relative free fatty-acid content, while targeted GC-MS supports broader fatty-acid remodeling and fluorescent uptake assays show increased exogenous fatty-acid uptake. FASN restoration partially restores relative free fatty-acid content and attenuates NEPC-associated and migratory phenotypes. Directional perturbation, rescue, AKT phosphorylation, and co-immunoprecipitation analyses further support the functional FGFRL1-FASN relationship. ONECUT2 is prioritized as a candidate downstream transcriptional regulator whose expression correlates with the neuroendocrine program. Together, these findings support an FGFRL1-FASN metabolic axis that regulates neuroendocrine lineage transdifferentiation and metastatic progression in ARIPC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell TransdifferentiationFatty Acid Synthase, Type IFatty AcidsProstatic Neoplasms, Castration-ResistantProstatic NeoplasmsReceptor, Fibroblast Growth Factor, Type 1MaleHumansAnimalsSignal TransductionLipogenesisCell Line, TumorGene Expression Regulation, NeoplasticMiceCell LineageCell Movement

Stichwörter der Autor:innen

AR pathway-independent prostate cancerFASNFGFRL1Fatty acid synthesisNeuroendocrine lineage transdifferentiation

Substanzen

Fatty Acid Synthase, Type IFatty AcidsFASN protein, humanReceptor, Fibroblast Growth Factor, Type 1

Autor:innen und Institutionen

  • Department of Urology, School of Medicine, The Second Affiliated Hospital of South China University of Technology (Guangzhou First People's Hospital), Guangzhou, 510180, China.
  • Guangdong Provincial Key Laboratory of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510230, China.
  • State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou…
  • Guangzhou National Laboratory, Guangzhou International Bio Island, Guangzhou, Guangdong Province, 510005, China.
  • Department of Urology, Guangzhou Baiyun District Women and Children's Hospital, Guangzhou, China.
  • Department of Liver, Gallbladder and Pancreatic Surgery, School of Medicine, The Second Affiliated Hospital of South China University of Technology (Guangzhou First People's Hospital), Guangzhou, 510180, China.

Förderung

  • Fundo para o Desenvolvimento das Ciências e da Tecnologia
  • National Natural Science Foundation of China

Zitieren

APA

Chen, Y., Lai, J., Chen, J., Zhou, Z., Xu, Q., Zhou, R., Li, J., Long, Y., Wureyimu, A., Su, J., Mei, X., Li, Y., Zhang, J., Liu, Y., Luo, J., He, H., Liu, S., & Zhong, W. (2026). The FGFRL1–FASN axis regulates neuroendocrine lineage transdifferentiation by modulating fatty acid synthesis in AR pathway-independent prostate cancer. Cancer Letters. https://doi.org/10.1016/j.canlet.2026.218769

Vancouver

Chen Y, Lai J, Chen J, Zhou Z, Xu Q, Zhou R, et al. The FGFRL1–FASN axis regulates neuroendocrine lineage transdifferentiation by modulating fatty acid synthesis in AR pathway-independent prostate cancer. Cancer Letters. 2026. doi:10.1016/j.canlet.2026.218769

BibTeX
@article{Chen2026,
  author = {Chen, Yupeng and Lai, Jiarun and Chen, Jian and Zhou, Ziqing and Xu, Qianfeng and Zhou, Rui and Li, Jinchuang and Long, Yusen and Wureyimu, Ailiyaerjiang and Su, Jiaming and Mei, Xinyue and Li, Yinglin and Zhang, Jun and Liu, Yongda and Luo, Jintai and He, Huichan and Liu, Shaoyou and Zhong, Weide},
  title = {The FGFRL1–FASN axis regulates neuroendocrine lineage transdifferentiation by modulating fatty acid synthesis in AR pathway-independent prostate cancer},
  journal = {Cancer Letters},
  year = {2026},
  doi = {10.1016/j.canlet.2026.218769}
}
Kostenlos starten →